Trump’s Drug Pricing Blueprint to be Explored at Upcoming Summit

In just a few short weeks, BIO will host its annual Patient and Health Advocacy Summit which brings together patient advocacy organizations, academia, regulators, biotechnology industry, and other stakeholders for two days of robust programming to discuss timely policy issues and share best practices.
Organizers announced a panel session for day one that will cover the Trump Administration’s “American Patients First Blueprint”, a proposed plan for addressing the cost of prescri